Montelukast Use Decreases Cardiovascular Events in Asthmatics.

Hoxha, Malvina; Tedesco, Calogero C; Quaglin, Silvana; Malaj, Visar; Pustina, Linda; Capra, Valerie; Evans, Jilly F; Sala, Angelo; Rovati, G Enrico

Hoxha, Malvina; Tedesco, Calogero C; Quaglin, Silvana; Malaj, Visar; Pustina, Linda; Capra, Valerie; Evans, Jilly F; Sala, Angelo; Rovati, G Enrico.

Afiliación

Hoxha M; Department of Pharmaceutical Sciences, University of Milan, Milano, Italy.
Tedesco CC; Department for Chemical-Toxicological and Pharmacologicsal Evaluation of Drugs, Catholic University Our Lady of Good Counsel, Tirana, Albania.
Quaglin S; Centro Cardiologico Monzino IRCCS, Milan, Italy.
Malaj V; Department of Industrial Engineering and Information, University of Pavia, Pavia, Italy.
Pustina L; Department of Economics, Faculty of Economics, University of Tirana, Tirana, Albania.
Capra V; Ministry of Education and Sports, Tirana, Albania.
Evans JF; Department of Pharmaceutical Sciences, University of Milan, Milano, Italy.
Sala A; University of Pennsylvania School of Medicine, Philadelphia, PA, United States.
Rovati GE; Department of Pharmaceutical Sciences, University of Milan, Milano, Italy.

Front Pharmacol ; 11: 611561, 2020.

Article en En | MEDLINE | ID: mdl-33519477

Palabras clave

asthma; cardiovascular diseases; inflammation; leukotriene receptors; montelukast

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Observational_studies Idioma: En Revista: Front Pharmacol Año: 2020 Tipo del documento: Article País de afiliación: Italia

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google